Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Ole Thorlacius-Ussing"'
Autor:
Lene Hjerrild Iversen, Claus L. Andersen, Derrick Renner, Thomas Reinert, Ole Thorlacius-Ussing, Desamparados Roda, Tenna V Henriksen, Alexey Aleshin, Andrés Cervantes, Noelia Tarazona, Per Vadgaard Andersen, Shruti Sharma, Susana Roselló, J.A. Carbonell-Asins, Dina Hafez, Anders Husted Madsen, Uffe S. Løve, Kåre Andersson Gotschalck, Amanda Frydendahl, Marisol Huerta, F. Gimeno-Valiente, Himanshu Sethi
Publikováno v:
Henriksen, T V, Tarazona, N, Frydendahl, A, Reinert, T, Gimeno-Valiente, F, Carbonell-Asins, J A, Sharma, S, Renner, D, Hafez, D, Roda, D, Huerta, M, Roselló, S, Madsen, A H, Løve, U S, Andersen, P V, Thorlacius-Ussing, O, Iversen, L H, Gotschalck, K A, Sethi, H, Aleshin, A, Cervantes, A & Andersen, C L 2022, ' Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences ', Clinical Cancer Research, vol. 28, no. 3, pp. 507-517 . https://doi.org/10.1158/1078-0432.CCR-21-2404
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Purpose: Sensitive methods for risk stratification, monitoring therapeutic efficacy, and early relapse detection may have a major impact on treatment decisions and patient management for stage III colorectal cancer patients. Beyond assessing the pred
Autor:
Mogens Tornby Stender, Louise Thorlacius-Ussing, Maja Ludvigsen, Henrik Vorum, Bent Honoré, Ole Thorlacius-Ussing
Publikováno v:
Current Issues in Molecular Biology
Volume 43
Issue 2
Pages 74-1056
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic characterization of colorectal cancer tissue from patients identifies novel putative protein biomarkers ', Current Issues in Molecular Biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/CIMB43020074
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers ', Current issues in molecular biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/cimb43020074
Current Issues in Molecular Biology, Vol 43, Iss 74, Pp 1043-1056 (2021)
Volume 43
Issue 2
Pages 74-1056
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic characterization of colorectal cancer tissue from patients identifies novel putative protein biomarkers ', Current Issues in Molecular Biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/CIMB43020074
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers ', Current issues in molecular biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/cimb43020074
Current Issues in Molecular Biology, Vol 43, Iss 74, Pp 1043-1056 (2021)
Colorectal cancer (CRC) is one of the leading causes of cancer-related death over the world. There is a great need for biomarkers capable of early detection and as targets for treatment. Differential protein expression was investigated with two-dimen
Publikováno v:
Straarup, D, Gotschalck, K A, Mikalone, R & Thorlacius-Ussing, O 2022, ' Preoperative findings on non-specific CT in patients with primary acute intestinal ischemia : a case-control study ', European Journal of Trauma and Emergency Surgery, vol. 48, no. 4, pp. 3025–3032 . https://doi.org/10.1007/s00068-021-01741-w
Purpose: Primary acute intestinal ischaemia (AII) is an abdominal catastrophe caused by intravascular obstruction of blood supply. It is difficult to diagnose. Computerized tomography (CT) scan is the modality of choice for diagnostic evaluation. Maj
Autor:
Ole Thorlacius-Ussing, Henriette Strøm Kahr, Aage Knudsen, Christian Torp-Pedersen, Ole Bjarne Christiansen, Inger Lise Gade, Signe Riddersholm
Publikováno v:
Kahr, H S, Christiansen, O B, Juul Riddersholm, S, Gade, I L, Torp-Pedersen, C, Knudsen, A & Thorlacius-Ussing, O 2021, ' The Timing of Venous Thromboembolism in Ovarian Cancer patients : A Nationwide Danish Cohort Study ', Journal of Thrombosis and Haemostasis, vol. 19, no. 4, pp. 992-1000 . https://doi.org/10.1111/jth.15235
BACKGROUND AND AIM: Venous thromboembolism (VTE) is associated with excess mortality and morbidity in cancer, and is influenced by patient-, tumor-, and treatment-related factors. We aimed to investigate the impact of such factors in a national cohor
Autor:
Rasmus Virenfeldt Flak, Ole Thorlacius-Ussing, Mogens Tornby Stender, Louise Stenholt, Lars Jelstrup Petersen
Publikováno v:
Flak, R V, Stender, M T, Stenholt, L, Thorlacius-Ussing, O & Petersen, L J 2020, ' Imaging response evaluation after local ablative treatments in locally advanced pancreatic cancer : an expedited systematic review ', H P B, vol. 22, no. 8, pp. 1083-1091 . https://doi.org/10.1016/j.hpb.2020.04.011
Background: Several local ablative modalities have been introduced for the treatment of locally advanced pancreatic cancer (LAPC). However, there is no consensus on how to evaluate the imaging response after treatment. A systematic review was perform
Publikováno v:
Kousgaard, S J, Nielsen, H L, Kirk, K F & Thorlacius-Ussing, O 2020, ' Consumption of yoghurt favours remission after faecal microbiota transplantation for chronic pouchitis ', International Journal of Colorectal Disease, vol. 35, no. 10, pp. 1955-1958 . https://doi.org/10.1007/s00384-020-03648-1
PURPOSE: The gut microbiota is conceivably a key factor in the aetiology of pouchitis. Faecal microbiota transplantation (FMT) has been suggested as a promising new treatment for chronic pouchitis, where treatment options often are few. However, litt
Autor:
Thomas Yssing Michaelsen, Hans Linde Nielsen, Ole Thorlacius-Ussing, Sabrina Just Kousgaard, Karina Frahm Kirk, Jakob Brandt, Mads Albertsen
Publikováno v:
Kousgaard, S J, Michaelsen, T Y, Nielsen, H L, Kirk, K F, Brandt, J, Albertsen, M & Thorlacius-Ussing, O 2020, ' Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis : a pilot study ', Scandinavian Journal of Gastroenterology, vol. 55, no. 4, pp. 421-429 . https://doi.org/10.1080/00365521.2020.1748221
Objectives: Research evidence suggests that chronic pouchitis is associated with intestinal dysbiosis. Faecal microbiota transplantation (FMT) has been proposed as a possible treatment. We performed a 6-month prospective, open-label, single-centre co
Autor:
Ole Bjarne Christiansen, Aage Knudsen, Anni Grove, Ole Thorlacius-Ussing, Christian Torp-Pedersen, Victor Vishwanath Iyer, Henriette Strøm Kahr
Publikováno v:
Kahr, H S, Christiansen, O B, Grove, A, Iyer, V V, Torp-Pedersen, C, Knudsen, A & Thorlacius-Ussing, O 2019, ' Venous thromboembolism in epithelial ovarian cancer : A prospective cohort study ', Thrombosis Research, vol. 181, pp. 112-119 . https://doi.org/10.1016/j.thromres.2019.07.027
Objective To determine the incidence of symptomatic and incidental venous thromboembolism (VTE) at time of diagnosis and throughout the first year, in patients with suspected epithelial ovarian cancer (EOC). Methods Patients were recruited consecutiv
Autor:
Martin Nygård Johansen, Ole Thorlacius-Ussing, Anders Christian Larsen, Benjamin Emil Stubbe, Henrik Krarup, Stine Dam Henriksen, Poul Henning Madsen, Inge Søkilde Pedersen
Publikováno v:
Stubbe, B E, Henriksen, S D, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, M N & Thorlacius-Ussing, O 2021, ' Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma ', Cancers, vol. 13, no. 22, 5717 . https://doi.org/10.3390/cancers13225717
Cancers, Vol 13, Iss 5717, p 5717 (2021)
Cancers
Cancers; Volume 13; Issue 22; Pages: 5717
Cancers, Vol 13, Iss 5717, p 5717 (2021)
Cancers
Cancers; Volume 13; Issue 22; Pages: 5717
Simple Summary Pancreatic adenocarcinoma (PDAC) is a disease with an incredibly grim prognosis. Most patients die within one year of receiving the diagnosis. There are currently very few tools to help the clinician decide between treatment options an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc9378191dcc9f3ceed6e6622a47f892
https://vbn.aau.dk/da/publications/c57e2f02-b218-4ee6-aacb-a6e60fc19a9d
https://vbn.aau.dk/da/publications/c57e2f02-b218-4ee6-aacb-a6e60fc19a9d
Autor:
Lone Sunde, Karina Rønlund, Ole Thorlacius-Ussing, Zohreh Ketabi, Anne Marie Jelsig, Niels Qvist, Charlotte Kvist Lautrup, John Gásdal Karstensen, Karin Wadt, Niels Jespersen
Publikováno v:
Jelsig, A M, Karstensen, J G, Jespersen, N, Ketabi, Z, Lautrup, C, Rønlund, K, Sunde, L, Wadt, K, Thorlacius-Ussing, O & Qvist, N 2021, ' Danish guidelines for management of non-APC-associated hereditary polyposis syndromes ', Hereditary Cancer in Clinical Practice, vol. 19, no. 1, 41 . https://doi.org/10.1186/s13053-021-00197-8
Jelsig, A M, Karstensen, J G, Jespersen, N, Ketabi, Z, Lautrup, C, Rønlund, K, Sunde, L, Wadt, K, Thorlacius-Ussing, O & Qvist, N 2021, ' Danish guidelines for management of non-APC-associated hereditary polyposis syndromes ', Hereditary Cancer in Clinical Practice, vol. 19, 41 . https://doi.org/10.1186/s13053-021-00197-8
Hereditary Cancer in Clinical Practice
Jelsig, A M, Karstensen, J G, Jespersen, N, Ketabi, Z, Lautrup, C, Rønlund, K, Sunde, L, Wadt, K, Thorlacius-Ussing, O & Qvist, N 2021, ' Danish guidelines for management of non-APC-associated hereditary polyposis syndromes ', Hereditary cancer in clinical practice, vol. 19, no. 1, pp. 41 . https://doi.org/10.1186/s13053-021-00197-8
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-9 (2021)
Jelsig, A M, Karstensen, J G, Jespersen, N, Ketabi, Z, Lautrup, C, Rønlund, K, Sunde, L, Wadt, K, Thorlacius-Ussing, O & Qvist, N 2021, ' Danish guidelines for management of non-APC-associated hereditary polyposis syndromes ', Hereditary Cancer in Clinical Practice, vol. 19, 41 . https://doi.org/10.1186/s13053-021-00197-8
Hereditary Cancer in Clinical Practice
Jelsig, A M, Karstensen, J G, Jespersen, N, Ketabi, Z, Lautrup, C, Rønlund, K, Sunde, L, Wadt, K, Thorlacius-Ussing, O & Qvist, N 2021, ' Danish guidelines for management of non-APC-associated hereditary polyposis syndromes ', Hereditary cancer in clinical practice, vol. 19, no. 1, pp. 41 . https://doi.org/10.1186/s13053-021-00197-8
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-9 (2021)
Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79848e1f7e6870e7d80f63b50cdd5dba
https://vbn.aau.dk/ws/files/451406951/Jelsig_et_al._2021_._Danish_guidelines_for_management_of_non_APC_associated_hereditary_polyposis_syndromes.pdf
https://vbn.aau.dk/ws/files/451406951/Jelsig_et_al._2021_._Danish_guidelines_for_management_of_non_APC_associated_hereditary_polyposis_syndromes.pdf